Rand兰德：2025年通过欧盟生物技术法案保护创新-兰德欧洲公司提交的证据报告（英文版）

Through evidence-based analysis, we have identified opportunities for the EU Biotech Act to orchestrate a coherent governance approach that balances scientific advancement with societal benefits and security considerations. While certain challenges such as adaptive oversight mechanisms for emerging sectors and cross-sector coordination are universal across biotechnology domains, each field presents unique technical and ethical considerations that merit tailored combinations of regulatory requ